QuikRead go CRP is a fast and simple rapid test for quantitative determination of C-reactive protein (CRP) in whole blood, serum and plasma with the QuikRead go instrument. The test gives reliable results within minutes and speeds up the path to the right diagnosis.
Orion Diagnostica is a leading IVD company focusing on point-of-care diagnostics. We develop, manufacture and market fast, reliable and easy to use diagnostic tests and test solutions for healthcare professionals, especially in primary healthcare. Our products have supported healthcare professionals in making correct treatment decisions and following up patients condition for more than 40 years. Our global footprint covers over 60 countries with 90 % of the sales coming from international markets. Our QuikRead® and QuikRead go® flagship products are used globally with close to 50,000 placed instruments. We have around 300 employees and our headquarters are located in Espoo, Finland. In 2017, our annual turnover was 54 MEUR. Orion Diagnostica Oy is owned by an investment fund managed by Axcel Management A/S, a leading Nordic private equity investment company.